CENTOGENElogo.jpg
CENTOGENE Extends Global Parkinson’s Disease Study
May 10, 2021 06:30 ET | CENTOGENE GmbH
Providing patients with genetic testing designed to accelerate the diagnosis and personalized treatment of Parkinson’s disease (PD) The Rostock International Parkinson's Disease (ROPAD) Study aims to...